NR 603 Primary Care Childbearing & Childrearing Family
Week 7 Quiz Exam Prep Document | 2026/2027 Edition | 250
Verified Questions
NR 603 Week 7 Quiz 2026-2027 Questions and Answers Already Graded A+. 100% Verified Solutions | Updated Per
Latest Guidelines | Detailed Rationales for Every Question
This comprehensive exam preparation document covers the Week 7 quiz for NR 603 Primary Care
Childbearing & Childrearing Family. It includes 250 verified questions with detailed rationales,
ensuring a thorough understanding of key concepts. Designed for the 2026/2027 academic year, this
resource is updated to reflect the latest clinical guidelines and best practices. With a focus on
high-yield content, it guarantees success for students aiming for an A+ grade.
Key Features:
Antepartum and postpartum care
Newborn screening and wellness
Contraceptive management
Common pediatric illnesses
Family dynamics and health promotion
Updates for 2026:
- Incorporated 2026 ACOG guidelines for prenatal care
- Updated immunization schedules per CDC 2027 recommendations
- Added new questions on telehealth in primary care
- Revised rationales to reflect current evidence-based practice
Abstract:
This document presents a curated collection of 250 verified questions for the NR 603 Week 7 quiz, focusing on
primary care for childbearing and childrearing families. Each question is accompanied by a detailed rationale that
explains the correct answer and addresses common misconceptions. The content encompasses a wide range of
topics including antepartum care, postpartum management, pediatric preventive care, and family health
promotion. Aligned with the 2026/2027 academic year, this resource incorporates the latest clinical guidelines
from ACOG, CDC, and AAP. The questions are designed to simulate the actual exam format, providing students
with a realistic practice experience. By studying these materials, learners can identify knowledge gaps and
reinforce their understanding of key concepts. This comprehensive approach ensures that students are
well-prepared to achieve a high score on the quiz.
Keywords:
NR 603, Primary Care Childbearing, Childrearing Family, Week 7 Quiz, 250 Questions, Detailed Rationales,
2026/2027, A+ Graded
Answer Format:
Each question is followed by the correct answer and a detailed rationale that explains why that answer is correct,
often referencing specific guidelines. Distractor rationales are also provided for incorrect options to clarify
common errors. The format is concise yet comprehensive, ensuring efficient review.
Compliance Checklist:
All questions verified by subject matter experts
Rationales cite current guidelines (ACOG, CDC, AAP)
Updated for 2026/2027 academic year
Page 1
, No outdated or irrelevant content
Pass guarantee backed by comprehensive coverage
Content Area Overview:
Content Area Questions Key Topics Weight
Antepartum Care 1-50 Prenatal visits, screening tests, high-risk 20%
pregnancy management, gestational
diabetes, preeclampsia
Intrapartum and Postpartum Care 51-100 Labor stages, pain management, postpartum 20%
complications, breastfeeding, newborn
transition
Newborn and Infant Care 101-150 Newborn screenings, immunizations, growth 20%
milestones, common neonatal conditions,
feeding
Child Health Maintenance 151-200 Well-child visits, developmental 20%
surveillance, injury prevention, nutrition,
chronic illness management
Family and Reproductive Health 201-250 Contraception, preconception counseling, 20%
family dynamics, adolescent health, cultural
considerations
Page 2
,Q1. A child presents for a well-child visit with no vaccines received after the first dose
of hepatitis B vaccine at birth. According to the CDC catch-up schedule, which of the
following vaccine series should be initiated simultaneously at this visit?
A. DTaP, IPV, MMR, varicella, and PCV13
B. DTaP, IPV, Hib, PCV13, and rotavirus (RV1 or RV5)
C. MMR, varicella, hepatitis A, and Tdap
D. PCV13, IPV, MMR, varicella, and influenza (if during season)
Correct Answer: A. DTaP, IPV, MMR, varicella, and PCV13
Rationale: For children aged 4 months through 6 years who have received only the birth
dose of hepatitis B, the CDC recommends starting DTaP, IPV, MMR, varicella, and PCV13
at the current visit, with subsequent doses as per catch-up. Option B includes Hib and
rotavirus, which are age-restricted and not typically given simultaneously with
MMR/varicella. Option C lacks DTaP and PCV13. Option D includes influenza only if
seasonal.
Why Wrong:
B - Rotavirus and Hib are not indicated for simultaneous administration with
MMR/varicella in this age group; also, rotavirus has age limits that may already be
exceeded.
C - DTaP and PCV13 are missing, both essential in early childhood catch-up.
D - Influenza vaccine is not part of the routine catch-up series; it is given annually and
not required for baseline catch-up.
Reference: CDC. (2026). Recommended Child and Adolescent Immunization Schedule.
Advisory Committee on Immunization Practices.
Q2. A patient with a history of a prior neural tube defect (NTD) pregnancy is
planning a pregnancy. What dose of folic acid is recommended to reduce the risk of
recurrence, and what additional prenatal counseling should be provided?
A. 0.4 mg daily with emphasis on dietary folate intake
B. 1 mg daily plus screening for MTHFR mutation
C. 4 mg daily starting at least 1 month before conception and continuing through first
trimester
D. 5 mg daily with genetic counseling for spina bifida
Correct Answer: C. 4 mg daily starting at least 1 month before conception and
continuing through first trimester
Rationale: For women with a prior NTD-affected pregnancy, high-dose folic acid (4
mg/day) is recommended starting 1 month before conception and through the first
trimester to reduce recurrence risk by 70%. Option A is the standard dose for primary
prevention. Option B is not standard; MTHFR testing is not recommended universally.
Option D dose of 5 mg is not standard; 4 mg is the accepted dose.
Page 3
, Why Wrong:
A - 0.4 mg is for primary prevention in low-risk women, not for recurrence risk
reduction.
B - 1 mg is insufficient for recurrence prevention, and MTHFR screening is not
indicated for all women with NTD history.
D - 5 mg is not the recommended dose; 4 mg is the standard high-dose regimen.
Reference: CDC. (2026). Folic Acid Recommendations. MMWR. Also ACOG Practice
Bulletin No. 187.
Q3. A postpartum patient at 6 weeks screens positive for depression on the Edinburgh
Postnatal Depression Scale (EPDS) with a score of 12. She denies thoughts of
self-harm and has no history of bipolar disorder. According to latest USPSFT
guidelines, what is the recommended next step?
A. Refer for cognitive behavioral therapy and repeat EPDS in 2 weeks
B. Initiate antidepressant therapy immediately with sertraline
C. Refer for comprehensive mental health evaluation and possible treatment
D. Reassure that postpartum dysphoria is normal and re-screen at 6 months
Correct Answer: C. Refer for comprehensive mental health evaluation and possible
treatment
Rationale: An EPDS score "e10 indicates possible depression. A score of 12 warrants a
comprehensive mental health evaluation to confirm diagnosis and guide treatment
(therapy, medication, or both). Option A delays treatment; option B is premature without
full evaluation; option D underestimates severity. Referral for evaluation is the
evidence-based recommendation.
Why Wrong:
A - A score of 12 is above the threshold; repeating the EPDS without further
intervention could delay care.
B - Immediate antidepressant initiation without a full diagnostic assessment may be
inappropriate, especially without suicidality or history.
D - A score of 12 is not normal dysphoria; postpartum depression requires active
management.
Reference: USPSTF. (2026). Screening for Depression in Adults. JAMA. Also ACOG
Committee Opinion No. 630.
Q4. After reviewing maternal medications, a breastfeeding patient is prescribed a
medication that is listed as 'contraindicated' in lactation databases. Which
pharmacologic property most strongly supports this classification?
A. High oral bioavailability and long half-life in the infant
B. High protein binding and large volume of distribution
C. Low molecular weight and high lipid solubility
Page 4
Week 7 Quiz Exam Prep Document | 2026/2027 Edition | 250
Verified Questions
NR 603 Week 7 Quiz 2026-2027 Questions and Answers Already Graded A+. 100% Verified Solutions | Updated Per
Latest Guidelines | Detailed Rationales for Every Question
This comprehensive exam preparation document covers the Week 7 quiz for NR 603 Primary Care
Childbearing & Childrearing Family. It includes 250 verified questions with detailed rationales,
ensuring a thorough understanding of key concepts. Designed for the 2026/2027 academic year, this
resource is updated to reflect the latest clinical guidelines and best practices. With a focus on
high-yield content, it guarantees success for students aiming for an A+ grade.
Key Features:
Antepartum and postpartum care
Newborn screening and wellness
Contraceptive management
Common pediatric illnesses
Family dynamics and health promotion
Updates for 2026:
- Incorporated 2026 ACOG guidelines for prenatal care
- Updated immunization schedules per CDC 2027 recommendations
- Added new questions on telehealth in primary care
- Revised rationales to reflect current evidence-based practice
Abstract:
This document presents a curated collection of 250 verified questions for the NR 603 Week 7 quiz, focusing on
primary care for childbearing and childrearing families. Each question is accompanied by a detailed rationale that
explains the correct answer and addresses common misconceptions. The content encompasses a wide range of
topics including antepartum care, postpartum management, pediatric preventive care, and family health
promotion. Aligned with the 2026/2027 academic year, this resource incorporates the latest clinical guidelines
from ACOG, CDC, and AAP. The questions are designed to simulate the actual exam format, providing students
with a realistic practice experience. By studying these materials, learners can identify knowledge gaps and
reinforce their understanding of key concepts. This comprehensive approach ensures that students are
well-prepared to achieve a high score on the quiz.
Keywords:
NR 603, Primary Care Childbearing, Childrearing Family, Week 7 Quiz, 250 Questions, Detailed Rationales,
2026/2027, A+ Graded
Answer Format:
Each question is followed by the correct answer and a detailed rationale that explains why that answer is correct,
often referencing specific guidelines. Distractor rationales are also provided for incorrect options to clarify
common errors. The format is concise yet comprehensive, ensuring efficient review.
Compliance Checklist:
All questions verified by subject matter experts
Rationales cite current guidelines (ACOG, CDC, AAP)
Updated for 2026/2027 academic year
Page 1
, No outdated or irrelevant content
Pass guarantee backed by comprehensive coverage
Content Area Overview:
Content Area Questions Key Topics Weight
Antepartum Care 1-50 Prenatal visits, screening tests, high-risk 20%
pregnancy management, gestational
diabetes, preeclampsia
Intrapartum and Postpartum Care 51-100 Labor stages, pain management, postpartum 20%
complications, breastfeeding, newborn
transition
Newborn and Infant Care 101-150 Newborn screenings, immunizations, growth 20%
milestones, common neonatal conditions,
feeding
Child Health Maintenance 151-200 Well-child visits, developmental 20%
surveillance, injury prevention, nutrition,
chronic illness management
Family and Reproductive Health 201-250 Contraception, preconception counseling, 20%
family dynamics, adolescent health, cultural
considerations
Page 2
,Q1. A child presents for a well-child visit with no vaccines received after the first dose
of hepatitis B vaccine at birth. According to the CDC catch-up schedule, which of the
following vaccine series should be initiated simultaneously at this visit?
A. DTaP, IPV, MMR, varicella, and PCV13
B. DTaP, IPV, Hib, PCV13, and rotavirus (RV1 or RV5)
C. MMR, varicella, hepatitis A, and Tdap
D. PCV13, IPV, MMR, varicella, and influenza (if during season)
Correct Answer: A. DTaP, IPV, MMR, varicella, and PCV13
Rationale: For children aged 4 months through 6 years who have received only the birth
dose of hepatitis B, the CDC recommends starting DTaP, IPV, MMR, varicella, and PCV13
at the current visit, with subsequent doses as per catch-up. Option B includes Hib and
rotavirus, which are age-restricted and not typically given simultaneously with
MMR/varicella. Option C lacks DTaP and PCV13. Option D includes influenza only if
seasonal.
Why Wrong:
B - Rotavirus and Hib are not indicated for simultaneous administration with
MMR/varicella in this age group; also, rotavirus has age limits that may already be
exceeded.
C - DTaP and PCV13 are missing, both essential in early childhood catch-up.
D - Influenza vaccine is not part of the routine catch-up series; it is given annually and
not required for baseline catch-up.
Reference: CDC. (2026). Recommended Child and Adolescent Immunization Schedule.
Advisory Committee on Immunization Practices.
Q2. A patient with a history of a prior neural tube defect (NTD) pregnancy is
planning a pregnancy. What dose of folic acid is recommended to reduce the risk of
recurrence, and what additional prenatal counseling should be provided?
A. 0.4 mg daily with emphasis on dietary folate intake
B. 1 mg daily plus screening for MTHFR mutation
C. 4 mg daily starting at least 1 month before conception and continuing through first
trimester
D. 5 mg daily with genetic counseling for spina bifida
Correct Answer: C. 4 mg daily starting at least 1 month before conception and
continuing through first trimester
Rationale: For women with a prior NTD-affected pregnancy, high-dose folic acid (4
mg/day) is recommended starting 1 month before conception and through the first
trimester to reduce recurrence risk by 70%. Option A is the standard dose for primary
prevention. Option B is not standard; MTHFR testing is not recommended universally.
Option D dose of 5 mg is not standard; 4 mg is the accepted dose.
Page 3
, Why Wrong:
A - 0.4 mg is for primary prevention in low-risk women, not for recurrence risk
reduction.
B - 1 mg is insufficient for recurrence prevention, and MTHFR screening is not
indicated for all women with NTD history.
D - 5 mg is not the recommended dose; 4 mg is the standard high-dose regimen.
Reference: CDC. (2026). Folic Acid Recommendations. MMWR. Also ACOG Practice
Bulletin No. 187.
Q3. A postpartum patient at 6 weeks screens positive for depression on the Edinburgh
Postnatal Depression Scale (EPDS) with a score of 12. She denies thoughts of
self-harm and has no history of bipolar disorder. According to latest USPSFT
guidelines, what is the recommended next step?
A. Refer for cognitive behavioral therapy and repeat EPDS in 2 weeks
B. Initiate antidepressant therapy immediately with sertraline
C. Refer for comprehensive mental health evaluation and possible treatment
D. Reassure that postpartum dysphoria is normal and re-screen at 6 months
Correct Answer: C. Refer for comprehensive mental health evaluation and possible
treatment
Rationale: An EPDS score "e10 indicates possible depression. A score of 12 warrants a
comprehensive mental health evaluation to confirm diagnosis and guide treatment
(therapy, medication, or both). Option A delays treatment; option B is premature without
full evaluation; option D underestimates severity. Referral for evaluation is the
evidence-based recommendation.
Why Wrong:
A - A score of 12 is above the threshold; repeating the EPDS without further
intervention could delay care.
B - Immediate antidepressant initiation without a full diagnostic assessment may be
inappropriate, especially without suicidality or history.
D - A score of 12 is not normal dysphoria; postpartum depression requires active
management.
Reference: USPSTF. (2026). Screening for Depression in Adults. JAMA. Also ACOG
Committee Opinion No. 630.
Q4. After reviewing maternal medications, a breastfeeding patient is prescribed a
medication that is listed as 'contraindicated' in lactation databases. Which
pharmacologic property most strongly supports this classification?
A. High oral bioavailability and long half-life in the infant
B. High protein binding and large volume of distribution
C. Low molecular weight and high lipid solubility
Page 4
